JPMorgan lowered the firm’s price target on Delek US to $19 from $26 and keeps a Neutral rating on the shares. The firm marked to market its Q3 crack assumptions for the refining group. Additionally, it updated 2025 estimates and established year-end 2025 price targets virus 2024 previously. The analyst is cautious on the group over the near term, saying the U.S. and global industry continue to run higher utilizations than demand calls for.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target lowered to $19 from $25 at Piper Sandler
- Delek US price target lowered to $22 from $24 at Morgan Stanley
- Delek US upgraded to Neutral from Underperform at Mizuho
- Delek US price target lowered to $22 from $33 at UBS
- Alphabet, Meta initiated: Wall Street’s top analyst calls